CoChat

14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T and myeloid immature acute leukemia

Open access
Di Giacomo, Danika, La Starza, Roberta, Gorello, Paolo, Pellanera, Fabrizia, Kalender Atak, Zeynep, De Keersmaecker, Kim, Pierini, Valentina, Harrison, Christine J, Arniani, Silvia, Moretti, Martina, Testoni, Nicoletta, De Santis, Giovanna, Roti, Giovanni, Matteucci, Caterina, Bassan, Renato, Vandenberghe, Peter, Aerts, Stein, Cools, Jan, Bornhauser, Beat, Bourquin, Jean-Pierre, Piazza, Rocco, Mecucci, Cristina · 2021 · Blood
Cited by 39

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Acute leukemias (AL) of ambiguous lineage are a heterogeneous group of high-risk leukemias characterized by co-expression of myeloid and lymphoid markers. In this study, we identified a distinct subgroup of immature acute leukemias characterized by a broadly variable phenotype, covering acute myeloid leukemia (AML M0 or M1), T/myeloid mixed phenotype acute leukemia (T/M MPAL), and early T-cell precursor acute lymphoblastic leukemia (ETP-ALL). Rearrangements at 14q32/BCL11B are the cytogenetic hallmark of this entity. In our screening of 915 hematological malignancies, there were 202 AML and 333 T-cell Acute Lymphoblastic Leukemia (T-ALL) (58 ETP, 178 non-ETP, 8 T/M MPAL, 89 not otherwise specified). We identified 20 cases of immature leukemias (4% of AML and 3,6% of T-ALL) harbouring four types of 14q32/BCL11B translocations: t(2,14)(q22.3;q32) (n=7), t(6;14)(q25.3;q32) (n=9), t(7;14)(q21.2;q32) (n=2) and t(8;14)(q24.2;q32) (n=2). The t(2;14) produced a ZEB2-BCL11B fusion transcript, while the other three rearrangements displaced transcriptionally active enhancer sequences close to BCL11B without producing fusion genes. All translocations resulted in the activation of BCL11B, a regulator of T-cell differentiation associated with transcriptional corepressor complexes in mammalian cells. The expression of BCL11B behaved as a disease biomarker, which was present at diagnosis but not in remission. Deregulation of BCL11B co-occurred with variants at FLT3 and at epigenetic modulators, most frequently DNMT3A, TET2 and/or WT1 gene. Transcriptome analysis identified a specific expression signature, with significant downregulation of BCL11B targets, and clearly separating BCL11B positive AL from AML, T-ALL, and ETP-ALL. Remarkably, ex-vivo drug sensitivity profile identified a panel of compounds with effective antileukemic activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.2020010510

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 39

Metadata

Authors
Di Giacomo, D., La Starza, R., Gorello, P., Pellanera, F., Kalender Atak, Z., De Keersmaecker, K., Pierini, V., Harrison, C. J., Arniani, S., Moretti, M., Testoni, N., De Santis, G., Roti, G., Matteucci, C., Bassan, R., Vandenberghe, P., Aerts, S., Cools, J., Bornhauser, B., Bourquin, J.-P., Piazza, R., & Mecucci, C.
Venue
Blood
Published
2021-04-19
Volume
138
Issue
9
Pages
773-784
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W3153276636
Cited by
39
References
9
FWCI
4.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T and myeloid immature acute leukemia. https://app.cochat.ai/papers/10.1182/blood.2020010510
The paper
Di Giacomo, D., La Starza, R., Gorello, P., Pellanera, F., Kalender Atak, Z., De Keersmaecker, K., Pierini, V., Harrison, C. J., Arniani, S., Moretti, M., Testoni, N., De Santis, G., Roti, G., Matteucci, C., Bassan, R., Vandenberghe, P., Aerts, S., Cools, J., Bornhauser, B., . . . Mecucci, C. (2021). 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T and myeloid immature acute leukemia. Blood. https://doi.org/10.1182/blood.2020010510

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.